Acceleron’s ACE-083 Fast Track’d for neurological disorder November 28, 2018https://seekingalpha.com/news/3412693-accelerons-aceminus-083-fast-trackd-neurological-disorder Acceleron’s ACE-083 Fast Track’d for neurological disorder http://acceleronpharma.com/product-candidates/ace-083/
Acceleron Receives FDA Orphan Drug Designation for ACE-083 in Facioscapulohumeral Muscular Dystrophy July 12, 2018http://investor.acceleronpharma.com/news-releases/news-release-details/acceleron-receives-fda-orphan-drug-designation-ace-083 Acceleron Receives FDA Orphan Drug Designation for ACE-083 in Facioscapulohumeral Muscular Dystrophy >>> july 12, 2018 / press release